D1 receptor antagonist-induced long-term depression in the medial prefrontal cortex of rat, in vivo: An animal model of psychiatric hypofrontality

Journal of Psychopharmacology

Volumn 23, Issue 6, 2009, Pages 672-685

  Coppa Hopman, R D ^a,b   Galle, J ^a   Pimkine, D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Addiction; D1 receptors; Dopamine; Glutamate; Hypofrontality; Long term depression; Long term potentiation; Medial prefrontal cortex; Negative symptoms; Schizophrenia

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; DOPAMINE 1 RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS CALLOSUM; DEPRESSION; ELECTRODE; EXCITATORY POSTSYNAPTIC POTENTIAL; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SYMPTOMATOLOGY; WORKING MEMORY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CHROMANS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTROPHYSIOLOGY; MALE; NEURONAL PLASTICITY; PREFRONTAL CORTEX; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 67651156063     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108091256     Document Type: Article

References (127)

1. Baldwin AE Sadeghin K Kelly AE (2002) Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. J Neurosci 22: 1063-1071.
2. Berridge CW Stalnaker TA (2002) Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse 46: 140-149.
3. Birrell JM Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set-shifting in the rat. J Neurosci 20: 4320-4324.
4. Bisaga A Comer SD Ward AS Popik P Kleber HD Fischman MW (2001) The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology (Berl) 157: 1-10.
5. Bliss TVP Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Phys 232: 331-356.
6. Blond O Crepel F Otani S (2002) Long-term potentiation in rat prefrontal slices facilitated by phased application of dopamine. Eur J Pharm 438: 115-116.
7. Britton DR Kebabian JW Curzon P (1991) Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930. Eur J Pharm 200: 89-93.
8. Brozoski TJ Brown RM Rosvold HE Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932.
9. Buckley PG Stahl SM (2007) Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac. Acta Psychiatr Scand 115: 93-100.
10. Carlson A Waters N Holm-Waters S Tedroff J Nilsson M Carlson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Ann Rev Pharmcol Toxicol 41: 237-260.
11. Carr DB O'Donnell P Card JP Sesack SR (1999) Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J Neurosci 19: 11049-11060.
12. Carr DB Sesack SR (1996) Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369: 1-15.
13. Carr DB Sesack SR (1998) Callosal terminals in the rat prefrontal cortex: synaptic targets in relation to GABA immunoreactive structures. Synapse 29: 193-205.
14. Carr DB Sesack SR (2000) GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38: 114-123.
15. Carr DB Sesack SR (2000a) Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 20: 3864-3873.
16. Carr DB Sesack SR (2000b) Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. J Comp Neurol 425: 275-283.
17. Chapman CA Trepel C Ivanco TL Froc DJ Wilson K Racine RJ (1998) Changes in field potentials and membrane currents in rat sensorimotor cortex following repeated tetanization of the corpus callosum in vivo. Cereb Cortex 8: 730-742.
18. Coyle JT Tsai G Goff D (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 1003: 318-327. (Pubitemid 38083065)
19. Davis KL Kahn RS Ko G Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474-1486.
20. Del Arco A Mora F (2001) Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors. Brain Res Bull 56: 125-130.
21. Di Ciano P Everitt BJ (2001) Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25: 341-360.
22. Ding CDD Gabbot PLA Totterdell S (2001) Differences in the laminar origin of projections from the medial prefrontal cortex to the nucleus accumbens shell and core regions in the rat. Brain Res 91: 81-89.
23. Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003: 119-130.
24. Flagel SB Robinson TE (2007) Quantifying the psychomotor activating effects of cocaine in the rat. Behav Pharmacol 18: 297-302.
25. Fletcher PJ (1995) Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine. Psychopharmacology (Berl) 118: 155-163.
26. Fletcher PJ Korth KM Sabijan MS DeSousa NJ (1998) Injections of D-amphetamine into the ventral pallidum increase locomotor activity and responding for conditioned reward: a comparison with injections into the nucleus accumbens. Brain Res 805: 29-40.
27. Fletcher PJ Sinyard J Salsali M Baker GB (2004) Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology (Berl) 174: 406-413.
28. Fletcher PJ Tenn CC Rizos Z Lovic V Kapur S (2005) Sensitization to amphetamine, but not phencyclidine, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 183: 190-200.
29. Floresco SB Seamans JK Phillips AG (1997) Selective roles for hippocampal, prefrontal cortical and ventral striatal circuits in radial-arm maze tasks with or without a delay. J Neurosci 17: 1880-1890.
30. Frey U Matthies H Reymann KG Matthies H (1991) The effect of dopaminergic D1 blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro. Neurosci Lett 129: 111-114.
31. Fuster JM (1995) Memory in the Cerebral Cortex. MIT Press. Cambridge, MA.
32. Fuster JM (1997) The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. Raven Press. Philadelphia, PA.
33. Gao WJ Krimer LS Goldman-Rakic PS (2001) Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Nat Acad Sci U S A 98: 295-300.
34. Goeders NE Smith JE (1986) Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 25: 191-199.
35. Goldman-Rakic PS (1995) Cellular basis of working memory. Neuron 14: 477-485.
36. Goldman-Rakic PS Selemon LD (1997) Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23: 437-458.
37. Goldstein M Deutch AY (1992) Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J 6: 2413-2421.
38. Goldstein RA Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
39. Gorelova N Yang CR (1997) Dopamine D1 receptor stimulation modulates a slowly inactivating Na+ current in layer V-VI prefrontal cortical neurons. Soc Neurosci Abstr 23: 1771.
40. Gray JA Roth BL (2007) The pipeline and future of drug development in schizophrenia. Mol Psychiatry 12: 904-922 (Epub ahead of print).
41. Green MF Nuechterlein KH Gold JM Barch DM Cohen J Essock S (2004) Approaching a concensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychol 56: 301-307.
42. Gurden H Takita M Jay TM (2000) Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci 20: 1-5.
43. Gurden H Tassin J-P Jay TM (1999) Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex synapses in vivo. - Neuroscience 94: 1019-1027.
44. Hirsch JC Crepel F (1991) Blockade of NMDA receptors unmasks a long-term depression in synaptic efficacy in rat prefrontal neurons in vitro. Exp Brain Res 85: 621-624.
45. Huang Y Kandel E (1995) D1/D5 receptor agonists induce a protein-synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci U S A 92: 2446-2450.
46. Isacson R Kull B Wahlested C Salmi P (2004) A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D1/5 receptors in the prefrontal cortex. Neuroscience 124: 33-42.
47. Izaki Y Takita M Akema T (2003) Compatibility of bidirectional synaptic plasticity on hippocampo-prefrontal cortex pathways in rats. Neurosci Lett 345: 69-71.
48. Japha K Koch M (1999) Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol. Psychopharmcology (Berl) 144: 347-354.
49. Jay TM Burette F Laroche S (1995) NMDA receptor-dependent LTP in the hippocampal afferent fibre system to the prefrontal cortex in the rat. Eur J Neurosci 7: 247-250.
50. Jentsch JD Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201-225.
51. Jentsch JD Tran A Le D Youngren KD Roth RH (1997) Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17: 92-99.
52. Kalivas PW Duffy P (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 56: 961-967.
53. Kebabian JW DeNinno MP Schoenleber R MacKenzie R Britton DR Asin KE (1992) A68930: a potent agonist specific for the dopamine D1 receptor. Neurochem Int 20: 157S - 160S.
54. Kinberg DY Farrah MJ (1993) A unified account of cognitive impairments following frontal lobe damage: the role of working memory in complex organized behaviour. J Exp Psychol 122: 411-428.
55. Kolb B (1984) Functions of the frontal cortex in rat: a comparative review. Brain Res 320: 65-98.
56. Kozlov AP Druzin MY Kurzina NP Malinina EP (2001) The role of D1-dependent dopaminergic mechanisms of the frontal cortex in delayed responding in rats. Neurosci Behav Physiol 31: 405-411.
57. Krystal JH Karper LP Seibyl JP Freeman GK Delaney R Bremner JD (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
58. Kusuki T Imahori Y Ueda S Inokuchi K (1997) Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain. Neuroreport 8: 2037-2040.
59. Lahti AC Koffel B LaPorte B Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19.
60. Laruelle M Kegeles LS Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003: 138-158.
61. Law-Tho D Desce J-M Crepel F (1995) Dopamine favours the emergence of long-term depression versus long-term potentiation in slices of rat prefrontal cortex. Neurosci Lett 188: 125-128.
62. Law-Tho D Hirsch JC Crepel F (1994) Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21: 151-160.
63. Lewis DA Glantz LA Pierri JN Sweet RA (2003) Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. Ann N Y Acad Sci 1003: 102-112.
64. Lewis BL O'Donnell P (2000) Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D1 dopamine receptors. Cereb Cortex 10: 1168-1175.
65. Lewis DA Pierri JN Volk DW Melchitzky DS Woo TU (1999) Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 4: 616-626.
66. Li S Cullen WK Anywl R Rowan MJ (2003) Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nat Neurosci 6: 526-531.
67. Lipina T Labrie V Weiner I Roder J (2005) Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar behavioural effects to clozapine in mouse models of schizophrenia. Psychopharmacology 179: 54-67.
68. Manoach DS Gollub RL Benson ES Searl MM Goff DC Halpern E (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory. Biol Psychiatry 48: 99-109.
69. Matsuda Y Marzo A Otani S (2006) The presence of background dopamine signal converts long-term synaptic depression to potentiation in rat prefrontal cortex. J Neurosci 26: 4803-4810.
70. Mattay VS Tessitore A Callicott JH Bertolino A Goldberg TE Chase TN (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51: 156-164.
71. Matthies H Becker A Schroeder H Kraus J Hollt V Krug M (1997) Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. Neuroreport 8: 3533-3535.
72. Meyer-Lindenberg A Miletich RS Kohn PD Esposito G Carson RE Quarantelli M (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5: 267-271.
73. Moghaddam B Bunney BS (1989) Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse 4: 156-161.
74. Moghaddam B Jackson ME (2003) Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003: 131-137.
75. Mulder AB Arts MPM Lopes da Silva FH (1997) Short- and long-term plasticity of the hippocampus to nucleus accumbens and prefrontal cortex pathways in the rat, in vivo. Eur J Neurosci 9: 1603-1611.
76. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
77. Nestler EJ Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278: 58-63.
78. O'Donnell P Grace AA (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15: 3622-3639.
79. O'grada C, Dinan, T (2007) Executive function in schizophrenia: what impact do antipsychotics have. Hum Psychopharmacol 6: 397-406.
80. Otani S Auclair N Desce J-M Roisin M-P Crepel F (1999) Dopamine receptors and groups I and II mGluRs cooperate for LTD induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci 19: 9788-9802.
81. Otani S Blond O Desce J-M Crepel F (1998) Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience 85: 669-676.
82. Otani S Daniel H Roison M-P Crepel F (2003) Dopaminergic modulation of long-term synaptic plasticity in rat prefrontal neurons. Cereb Cortex 13: 1251-1256.
83. Otmakhova NA Lisman JE (1996) D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J Neurosci 16: 7478-7486.
84. Ozaki M Sasner M Yano R Lu HS Buonanno A (1997) Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390: 691-694.
85. Pantelis C Barnes TRE Nelson HE Tanner S Weatherly L Owen AM (1997) Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120: 1823-1843.
86. Pantelis C Stuart GW Nelson HE Robbins TW Barnes TRE (2001) Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry 158: 1276-1285.
87. Paxinos G Watson C (1997) Compact Third Edition: The Rat Brain in Stereotaxic Coordinates. Academic Press. San Diego, CA.
88. Phillips AG Ahn S Floresco SB (2004) Magnitude of dopamine release in media prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 24: 533-547.
89. Pierce RC Reader DC Hicks J Morgan ZR Kalivas BW (1998) Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioural sensitization to cocaine. Neuroscience 82: 1103-1114.
90. Racine RJ Chapman CA Trepel C Teskey GC Milgram NW (1995) Post-activation potentiation in the neocortex: IV. Multiple sessions required for induction of long-term potentiation in the chronic preparation. Brain Res 702: 87-93.
91. Robinson TE Camp DM (1987) Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behaviour, and spontaneous nocturnal locomotion. Pharmacol Biochem Behav 26: 821-827.
92. Samini M Fakhrian R Mohagheghi M Dehpour AR (2000) Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice. Hum Psychopharmacol Clin Exp 15: 95-101.
93. Sawaguchi T Goldman-Rakic PS (1994) The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71: 515-528.
94. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80: 1-27.
95. Schultz SH North SW Shields CG (2007) Schizophrenia: a review. Am Fam Physician 75: 1821-1829.
96. Seamans JK Floresco SB Phillips AG (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18: 1613-1621.
97. Seeman P Weinshenker D Quiron R Srivastava LK Bhardwaj SK Grandy DK (2005) Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A 102: 3513-3518.
98. Selemon LD Goldman-Rakic PS (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45: 17-25.
99. Serafim AP Felicio LF (2001) Dopaminergic modulation of grooming behaviour in virgin and pregnant rats. Braz J Med Biol Res 34: 1465-1470.
100. Sesack SR Snyder CL Lewis DA (1995) Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 363: 264-280.
101. Smith JK Neill JC Costall B (1996) Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer. Pharmacol Biochem Behav 57: 843-849.
102. Stahl SM Buckley PF (2007) Negative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr Scand 115: 4-11.
103. Stefani MR Moghaddam B (2006) Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J Neurosci 26: 8810-8818.
104. Stefansson H Sigurdsson E Steinthorshdottir V Bjornsdottir S Sigmundsson T Ghosh S (2002) Neuroregulin-1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877-892.
105. Sutton MA Beninger RJ (1999) Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors. Psychopharmacology (Berl) 144: 95-110.
106. Swanson-Park JL Coussens CM Mason-Parker SE Raymond CR Hargeaves EL Dragunow M (1999) A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience 92: 485-497.
107. Taber MT Das S Fibiger HC (1995) Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 65: 1407-1410.
108. Tamminga CA (2004) Structure of the human prefrontal cortex. Am J Psychiatry 161: 8.
109. Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67: 36-42.
110. Taylor JR Horger BA (1999) Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization. Psychopharmacology (Berl) 142: 31-40.
111. Taylor JR Robbins TW (1984) Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl) 84: 405-412.
112. Taylor JR Robbins TW (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology (Berl) 90: 390-397.
113. Tenn CC Fletcher PJ Kapur S (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64: 103-114.
114. Tenn CC Kapur S Fletcher PJ (2005) Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology 180: 366-376.
115. Tseng K-Y O'Donnell P (2003) Dopamine-glutamate interactions in the control of cell excitability in medial prefrontal excitability in medial prefrontal cortical pyramidal neurons from adult rats. Ann N Y Acad Sci 1003: 476-478.
116. Tzechentke TM (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63: 241-320.
117. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227-462.
118. Ungerleider LG Courtney SM Haxby JV (1998) A neural system for human visual working memory. Proc Natl Acad Sci U S A 95: 883-890.
119. Uylings HB van Eden CG (1990) Qualitative and quantitative comparison of the prefrontal cortex in rat an in primates, including humans. Prog Brain Res 85: 31-62.
120. Weinberger DR Zalcman S Marder SR (2004) Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56: 301-307.
121. Williams GV Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-575.
122. Wolf ME (1998) The role of excitatory amino acids in behavioural sensitization to psychomotor stimulants. Prog Neurobiol 5: 679-720.
123. Wolf ME (2002) Glutamate and Addiction. Humana Press. Totowa, NJ.
124. Wolf ME (2003) LTP may trigger addiction. Mol Interv 3: 248-252.
125. Wolf ME Sun X Mangiavacchi S Chao SZ (2004) Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47: 61-79.
126. Yang CR Seamans JK Gorelova N (1996) Electrophysiological and morphological properties of layers V-VI principal pyramidal cells in rat prefrontal cortex in vitro. J Neurosci 16: 1904-1921.
127. Zajaczkowski W Czyrak A Wedzony K (2003) A competitive agonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801. Pol J Pharmacol Pharm 55: 703-711.